Dysregulation of Leptin and Testosterone Production and Their Receptor Expression in the Human Placenta with Gestational Diabetes Mellitus

Placenta

Volumn 31, Issue 7, 2010, Pages 581-588

  Uzelac, P S ^a   Li, X ^a   Lin, J ^a   Neese, L D ^a   Lin, L ^a   Nakajima, S T ^a   Bohler, H ^a   Lei, Z ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Androgen receptor; FGF2; Gestational diabetes mellitus; Leptin; Placenta

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; AROMATASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450 ISOENZYME; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FLUTAMIDE; HORMONE RECEPTOR; HYDROXYSTEROID DEHYDROGENASE; INSULIN RECEPTOR; INSULIN RECEPTOR ALPHA; INSULIN RECEPTOR BETA; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; NUCLEAR PROTEIN; NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 2 PROTEIN; NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 PROTEIN; PEPTIDE HORMONE; PLACENTA ENZYME; PROGESTERONE RECEPTOR; RIBOSOME PROTEIN; STEROID; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANDROGEN; ANDROSTANOLONE;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; FEMALE; GENE OVEREXPRESSION; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PLACENTA VILLUS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TESTOSTERONE SYNTHESIS; WESTERN BLOTTING; BIOSYNTHESIS; METABOLISM;

ANDROGENS; DIABETES, GESTATIONAL; DIHYDROTESTOSTERONE; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LEPTIN; PLACENTA; PREGNANCY; RECEPTORS, ANDROGEN; RECEPTORS, LEPTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE;

EID: 77954083084     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.04.002     Document Type: Article

References (45)

1. Desoye G., and Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30 Suppl. 2 (2007) S120-S126
2. Lei Z.M., and Rao C.V. Endocrinology of trophoblastic tissue. In: Becker K.L. (Ed). Principles and practice of endocrinology and metabolism. 3rd ed. (2001), Lippincott Williams & Wilkins, Philadelphia 180-186
3. Barnes-Powell L.L. Infants of diabetic mothers: the effects of hyperglycemia on the fetus and neonate. Neonatal Netw 26 5 (2007) 283-290
4. Hayes C. Long-term prognostic factors in the diagnosis of gestational diabetes. Br J Nurs 18 9 (2009) 523-524 6
5. Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet 104 Suppl. 1 (2009) S25-S26
6. Saldeen P., Olofsson P., and Laurini R.N. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 105 2 (2002) 136-142
7. Daskalakis G., Marinopoulos S., Krielesi V., Papapanagiotou A., Papantoniou N., Mesogitis S., et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand 87 4 (2008) 403-407
8. Nelson S.M., Coan P.M., Burton G.J., and Lindsay R.S. Placental structure in type 1 diabetes: relation to fetal insulin, leptin, and IGF-I. Diabetes 58 11 (2009) 2634-2641
9. Barbieri R.L., Saltzman D.H., Torday J.S., Randall R.W., Frigoletto F.D., and Ryan K.J. Elevated concentrations of the beta-subunit of human chorionic gonadotropin and testosterone in the amniotic fluid of gestations of diabetic mothers. Am J Obstet Gynecol 154 5 (1986) 1039-1043
10. Nestler J.E. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I. Endocrinology 121 5 (1987) 1845-1852
11. Montelongo A., Lasuncion M.A., Pallardo L.F., and Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 41 12 (1992) 1651-1659
12. Ategbo J.M., Grissa O., Yessoufou A., Hichami A., Dramane K.L., Moutairou K., et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 91 10 (2006) 4137-4143
13. Uzelac P., Lee J., Zhang X., Mirazei R., Paulson R., and Stanczyk F. Irregular periods as a marker of increased insulin and testosterone levels in the gestational diabetic patient. Fertil Steril 84 Suppl. 1 (2005) S-428
14. Uzelac P., Lee J., Zhang X., Paulson R., Miller D., and Stanczyk F. Gestational diabetes augments hyperandrogenemia in the third trimester of pregnancy. J Soc Gynecol Investig 12 Suppl. 2 (2005) 620
15. Uzelac P., Stanczyk F., and Nakajima S. Insulin, not human chorionic gonadotropin, is correlated with testosterone and free testosterone in gestational diabetes. Fertil Steril 87 Suppl. 2 (2007) O-13
16. Kleiblova P, Dostalova I, Bartlova M, Lacinova Z, Ticha I, Krejci V, et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 314(1):150-6.
17. Wang H., Li R., and Hu Y. The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner. Endocrinology 150 7 (2009) 3301-3307
18. Zuck B., Goepfert C., Nedlin-Chittka A., Sohrt K., Voigt K.D., and Knabbe C. Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. J Steroid Biochem Mol Biol 41 3-8 (1992) 659-663
19. Yoshimura K., Kaji H., Kamidono S., and Chihara K. Expression of basic fibroblast growth factor (FGF-2) messenger ribonucleic acid is regulated by testosterone in the rat anterior pituitary. Growth Factors 10 4 (1994) 253-258
20. Tang W., Zheng S.B., and Zhang J.H. Effects of androgen and estrogen on the expressions of basic fibroblast growth factor, transforming growth factor and smoothelin. Di Yi Jun Yi Da Xue Xue Bao 22 1 (2002) 13-16
21. Gonzalez-Herrera I.G., Prado-Lourenco L., Pileur F., Conte C., Morin A., Cabon F., et al. Testosterone regulates FGF-2 expression during testis maturation by an IRES-dependent translational mechanism. FASEB J 20 3 (2006) 476-478
22. Di Blasio A.M., Carniti C., Vigano P., Florio P., Petraglia F., and Vignali M. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. Mol Hum Reprod 3 12 (1997) 1119-1123
23. Burleigh D.W., Stewart K., Grindle K.M., Kay H.H., and Golos T.G. Influence of maternal diabetes on placental fibroblast growth factor-2 expression, proliferation, and apoptosis. J Soc Gynecol Investig 11 1 (2004) 36-41
24. Briana D.D., and Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 16 10 (2009) 921-937
25. Schulz L.C., Widmaier E.P., Qiu J., and Roberts R.M. Effect of leptin on mouse trophoblast giant cells. Biol Reprod 80 3 (2009) 415-424
26. Coya R., Martul P., Algorta J., Aniel-Quiroga M.A., Busturia M.A., and Senaris R. Effect of leptin on the regulation of placental hormone secretion in cultured human placental cells. Gynecol Endocrinol 22 11 (2006) 620-626
27. Rumer K.K., and Winn V.D. Biphasic effect of leptin on human cytotrophoblast invasion. Reprod Sci 16 Suppl. 3 (2009) 261A
28. Nestler J.E. Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts. Endocrinology 127 5 (1990) 2064-2070
29. Nestler J.E. Regulation of the aromatase activity of human placental cytotrophoblasts by insulin, insulin-like growth factor-I, and -II. J Steroid Biochem Mol Biol 44 4-6 (1993) 449-457
30. Dokras A., Spaczynski R.Z., Behrman H.R., and Duleba A.J. Testosterone levels in pregnant women correlate with the insulin response during the glucose tolerance test. Fertil Steril 79 3 (2003) 492-497
31. McRobie D.J., Korzekwa K.R., Glover D.D., and Tracy T.S. The effects of diabetes on placental aromatase activity. J Steroid Biochem Mol Biol 63 1-3 (1997) 147-153
32. Macaulay J.O., Warne G.L., and Krozowski Z.S. Human placenta contains a high affinity R1881 binding site that is not the androgen receptor. J Steroid Biochem 29 5 (1988) 497-503
33. Horie K., Takakura K., Imai K., Liao S., and Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod 7 10 (1992) 1461-1466
34. Iwamura M., Abrahamsson P.A., Benning C.M., Cockett A.T., and di Sant'Agnese P.A. Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem 42 6 (1994) 783-788
35. Chan C.C., Lao T.T., Ho P.C., Sung E.O., and Cheung A.N. The effect of mifepristone on the expression of steroid hormone receptors in human decidua and placenta: a randomized placebo-controlled double-blind study. J Clin Endocrinol Metab 88 12 (2003) 5846-5850
36. Hill D.J., Tevaarwerk G.J., Caddell C., Arany E., Kilkenny D., and Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab 80 9 (1995) 2626-2632
37. Chen C.H., Poucher S.M., Lu J., and Henry P.D. Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2 1 (2004) 33-43
38. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 30 Suppl. 2 (2007) S169-S174
39. Eisner J.R., Dumesic D.A., Kemnitz J.W., and Abbott D.H. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 85 3 (2000) 1206-1210
40. Recabarren S.E., Padmanabhan V., Codner E., Lobos A., Duran C., Vidal M., et al. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab 289 5 (2005) E801-E806
41. Hauguel-de Mouzon S., and Lepercq J. Placental leptin and pregnancy pathologies. Gynecol Obstet Fertil 29 7-8 (2001) 534-537
42. Lepercq J., Cauzac M., Lahlou N., Timsit J., Girard J., Auwerx J., et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 47 5 (1998) 847-850
43. Radaelli T., Varastehpour A., Catalano P., and Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52 12 (2003) 2951-2958
44. Alonso A., Del Rey C.G., Navarro A., Tolivia J., and Gonzalez C.G. Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta. Gynecol Endocrinol 22 9 (2006) 526-535
45. Lea R.G., Howe D., Hannah L.T., Bonneau O., Hunter L., and Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod 6 8 (2000) 763-769